Encouraging Data on Roche’s Lampalizumab – Analyst Blog
Roche ( RHHBY ) recently announced encouraging data on lampalizumab from a multi centre randomized phase II study, MAHALO. …read more
Roche ( RHHBY ) recently announced encouraging data on lampalizumab from a multi centre randomized phase II study, MAHALO. …read more
Actelion ( ALIOF ) recently announced that data on pipeline candidate Opsumit from a pivotal phase III study, SERAPHIN (Study …read more
AECOM Technology Corporation ( ACM ) has received a contract from U.S. Agency for International Development (USAID) for the South …read more
On Aug 29, 2013 we maintained our Neutral recommendation on China Unicom Hong Kong Limited ( CHU ). We expect …read more
Here are 5 stocks added to the Zacks #1 Rank (“strong buy”) List today Banner Corporation ( BANR …read more
The agriculture sector is in for a boom with the U.S. Department of Agriculture (USDA) forecasting a record net farm …read more
The Toronto Dominion Bank ( TD ) reported fiscal third quarter 2013 (ended Jul 31) adjusted earnings of C$1.65 per …read more
Splunk Inc. ( SPLK ) reported fiscal second quarter 2014 loss of 13 cents per share, which was wider than …read more
JA Solar Holdings Co. Ltd. ( JASO ) announced a loss of 58 cents per American Depositary Share (ADS) in …read more
Primero Mining Corp ( PPP ) has moved higher as of late, but there could definitely be trouble on the …read more